Primary |
Drug Use For Unknown Indication |
81.3% |
Schizophrenia |
18.8% |
|
|
Secondary |
Schizophrenia |
41.5% |
Drug Use For Unknown Indication |
10.8% |
Depression |
10.3% |
Schizophrenia, Paranoid Type |
8.5% |
Product Used For Unknown Indication |
5.8% |
Prophylaxis |
4.0% |
Analgesic Therapy |
3.0% |
Parkinsonism |
2.8% |
Anxiety |
2.3% |
Operative Haemorrhage |
2.0% |
Constipation |
1.0% |
Diabetes Mellitus |
1.0% |
General Anaesthesia |
1.0% |
Hypercholesterolaemia |
1.0% |
Hypotonia |
1.0% |
Sedative Therapy |
1.0% |
Shock |
1.0% |
Partial Seizures |
0.8% |
Psychiatric Symptom |
0.8% |
Ill-defined Disorder |
0.5% |
|
Urinary Retention |
35.7% |
Parkinsonism |
9.5% |
Cardiac Failure |
7.1% |
Coma |
7.1% |
Death |
7.1% |
Platelet Count Increased |
7.1% |
Treatment Noncompliance |
7.1% |
Overdose |
4.8% |
Suicide Attempt |
4.8% |
Gait Disturbance |
2.4% |
Hepatic Function Abnormal |
2.4% |
Rhabdomyolysis |
2.4% |
Shock |
2.4% |
|
Concomitant |
Schizophrenia |
46.3% |
Product Used For Unknown Indication |
6.9% |
Insomnia |
6.1% |
Bipolar Disorder |
4.0% |
Akathisia |
3.9% |
Schizophrenia, Paranoid Type |
3.6% |
Extrapyramidal Disorder |
3.5% |
Depression |
3.1% |
Constipation |
2.6% |
Drug Use For Unknown Indication |
2.4% |
Paranoia |
2.1% |
Parkinsonism |
2.1% |
Diabetes Mellitus |
1.9% |
Nausea |
1.9% |
Prophylaxis |
1.9% |
Epilepsy |
1.8% |
Parkinson's Disease |
1.8% |
Schizophrenia, Undifferentiated Type |
1.7% |
Hypertension |
1.4% |
Mania |
1.2% |
|
Psychiatric Symptom |
18.8% |
Schizophrenia |
11.6% |
Hepatic Function Abnormal |
7.1% |
Pneumonia |
7.1% |
Fall |
6.3% |
Pancytopenia |
5.4% |
Pulmonary Oedema |
5.4% |
White Blood Cell Count Increased |
5.4% |
Completed Suicide |
3.6% |
Pneumonia Aspiration |
3.6% |
Restlessness |
3.6% |
Weight Decreased |
3.6% |
Drug Rash With Eosinophilia And Systemic Symptoms |
2.7% |
Myalgia |
2.7% |
Neuroleptic Malignant Syndrome |
2.7% |
Pregnancy |
2.7% |
Vomiting |
2.7% |
Blood Creatine Phosphokinase Increased |
1.8% |
Blood Glucose Increased |
1.8% |
Blood Lactate Dehydrogenase Increased |
1.8% |
|